Lingkong Takeoff Is Now: Shaanxi Xixian New Area's Life Science and Health Tech Industrial Project Recruitment in Full Swing!

As one of the most innovative and dynamic emerging industries, the life and health technology sector has long been designated as a pillar industry or a key priority for development by numerous cities.

In the 14th Five-Year Plan and Outline of Long-Range Objectives Through the Year 2035 released by various provinces and municipalities last year, keywords such as biopharmaceutical industry, biopharmaceuticals, digital health management, and medical healthcare were frequently mentioned, underscoring the emphasis and strategic planning placed on the development of the biopharmaceutical sector across different regions.

Amid this wave, Xi’an has explicitly designated the biopharmaceutical industry as one of the six pillar industries within its “advanced manufacturing” sector, and has successively issued the Action Plan for the Development of Xi’an’s Biopharmaceutical Industry Cluster (2020–2022) and Several Policy Recommendations on Promoting the Development of Xi’an’s Biotechnology Industry, thereby attracting more biopharmaceutical enterprises and talent to settle in Xi’an.

As China’s seventh national-level new area and one of the key hubs for Xi’an’s biopharmaceutical industry, Xixian New Area has actively responded to Xi’an’s strategies and plans for biopharmaceutical industry development in recent years, establishing corresponding biopharmaceutical and general health industrial parks within clusters such as Airport New City and Qinhan New City.

Among them, the Airport New City is the only area in Xi'an that simultaneously possesses “Airside, Free Trade Zone, Bonded Area, Port, Cross-Border, Air Traffic Rights“The six major open platforms can provide strong support for the high-quality development of the life and health technology industry.”

The Airport New City, located in the northwest of the Xixian New Area, centers on Xi'an Xianyang International Airport and boasts a highly robust multimodal transportation network and strong advantages in airport-related industries.

In the development of the biopharmaceutical and broader health industry, although the Airport New City was not the earliest area in the Xi’an region to attempt building a biopharmaceutical and health industry cluster, it now leverages itsIndustrial Clusters, Policies, and Supporting ResourcesWith its advantages and support, the Airport New City has laid a solid foundation for the development of the regional life and health technology industry.

As one of the models for inland opening-up, the Airport New City boasts six major open platforms that have created its unique locational advantages. These platforms have also fostered an agglomeration effect for resources related to the airport economy, attracting a cohort of biopharmaceutical enterprises—including Pharmaron, Shaanxi Pharmaceutical Group, Guorui Yinuo, and Meri Zhongcheng—to establish operations there, thereby gradually shaping a robust industrial cluster.

Among them, as a leading enterprise in China’s CRO sector, Pharmaron offers an integrated, end-to-end CRO+CMO service platform that spans multiple interdisciplinary fields, including laboratory chemistry, biological sciences, drug safety evaluation, chemical and formulation process development and manufacturing, and clinical research services. This enables Pharmaron to provide biopharmaceutical companies with comprehensive service solutions ranging from drug development to production.

Furthermore, the animal vaccine production base built by Meili Zhongcheng in the Airport New City, along with its R&D and quality control laboratories, can also support the development of the biopharmaceutical industry in the entire Airport New City.

In addition, Guorui Yinuo, the first non-clinical drug safety research institution in Shaanxi Province to pass the national Good Laboratory Practice (GLP) certification for drugs, has also been established in the Airport New City.

Baihong Regenerative Medicine, which recently established its presence in the Airport New City, is a group company specializing in regenerative medicine healthcare and regenerative aesthetic medicine, integrating industry, academia, and research, as well as production, supply, and sales. Indeed, this represents a significant project launch within the entire Shaanxi province.

It can be seen that in the Airport New City, aA full-spectrum biopharmaceutical and broader health industry chain encompassing R&D, manufacturing, testing, and servicesAccelerating formation.

To attract more upstream and downstream enterprises in the biopharmaceutical and broader health industries, the Airport New City has issued multiple policy documents this year alone to boost the development of the life and health technology sector, aiming toIncentive measures, tax incentives, talent guarantees, etc.Attract a large number of high-level talents and high-quality medical enterprises to settle in, creating a biopharmaceutical industry cluster.

Notably, the “Policy Measures of Xixian New Area Airport New City on Accelerating the Agglomeration and Development of the Biopharmaceutical Industry,” released in May this year, explicitly stipulates that eligible biopharmaceutical and general health enterprises may receive a range of financial support, including investment subsidies, certification subsidies, rewards for product market launch, and rewards for product industrialization, depending on their circumstances. The document further states that service-oriented biopharmaceutical and general health enterprises and platforms, upon accreditation, can receive subsidies of up to RMB 10 million. For high-quality biopharmaceutical and general health projects meeting the relevant criteria, the Administrative Committee of Airport New City will also provide tailored, case-by-case support solutions.

Meanwhile, to provide greater support for the establishment of enterprises in the biopharmaceutical and broader health sectors, the Airport New City has also introduced a range of preferential tax policies. For instance, small and medium-sized enterprises that meet specified criteria can enjoy “Two-Year Exemption, Three-Year Half Reduction” tax incentives, with large enterprises eligible for tax reductions of up to 35% of the retained portion at both the new district and new city levels.

Furthermore, the Airport New City will also establish and formA Life and Health Industry Fund with a Total Scale of RMB 200 Million, which not only provides a significant impetus for the development of the life and health technology industry in the Airport New City, but also serves as a favorable measure to support the growth of enterprises stationed there.

In terms of supporting resources, the Airport New City fully leverages the policy services and operational resources of existing industrial platforms to establish an integrated industrial service system for settled biopharmaceutical and general health enterprises. This system encompasses infrastructure, spatial facilities, business amenities, living facilities, government services, financial services, and corporate operational services.

In this regard, it is necessary to mentionQin Chuang Yuan: The General Platform for Innovation-Driven Development in Shaanxi ProvinceAs an innovation-driven platform characterized by market orientation, shared resources, openness, and comprehensiveness, Qin Chuang Yuan has consistently prioritized the deep integration of industrial chains and innovation chains as its core development strategy. With Xixian New Area serving as its primary showcase, it has established three major development objectives: building a multi-dimensional collaborative “incubator,” a technology transfer “accelerator,” and a dual-chain integration “promoter.”

Shouldering the critical mission of driving innovation-led development, Qin Chuang Yuan has gradually formed a framework that includesPolicy Support, Industrial Ecosystem Support, Sci-Tech Finance Support, and Shared Empowerment Supporta comprehensive industrial development support system, which precisely provides extensive reference experience and resource support for the Airport New City to promote the development of the biopharmaceutical and general health industries.

Furthermore, in terms of research and medical resources, Shaanxi Province is home to more than 40 Grade-A tertiary hospitals, over 200 key laboratories, and 1,200 scientific research institutions. The Airport New City can effectively synergize with these resources, thereby providing substantial scientific research capacity and talent support for the development of enterprises in the life and health technology sector.

Leveraging the foundation for life and health technology industry development built upon three core advantages—industrial resource agglomeration, policy support, and a comprehensive supporting service system—the construction of the life and health technology industrial cluster in the Airport New City has gradually been put on the right track.

To further attract top talent, leverage the distinctive advantages of the Airport New City, and promote the formation of a life and health technology industrial cluster in the Airport New Area, Free Trade Blue Bay No. 1 of the Airport New City—Life and Health Technology Industrial Park has officially launched recruitment for biopharmaceutical and general health projects.Focusing on key areas such as gene therapy, traditional Chinese medicine (TCM), vaccines, biological reagents, monoclonal/polyclonal antibodies, and novel digital therapeutics.。

As the core component of the Qin Chuang Yuan Airport Industry Cluster and the Open Cooperation Demonstration Zone, Free Trade Blue Bay is a distinctive airport-oriented sci-tech innovation industrial cluster in Shaanxi. Leveraging the pioneering advantages of the Free Trade Zone, it targets the airport industry, airline headquarters, and the digital economy to create a “special zone” within the FTZ, an open highland, and a blue bay for technological innovation with intensive industrial agglomeration.

Located within it, Free Trade Blue Bay No. 1 — Life and Health Technology Industrial Park serves as the hub for biopharmaceuticals and the broader health industry in the Airport New City, primarily focusing on life and health technologies. Over the years of development, it has formedA “2+2+1” life science industry system led by intelligent medical equipment and innovative drugs, characterized by aerospace medical aesthetics and digital health management, and supported by smart supply chain platforms。

Free Trade Blue Bay No. 1 — Life and Health Technology Industrial Park

Closed-door sessions on the planning and layout of Xixian New Area and Airport New City will also be held during the project recruitment period.At that time, government leaders from both the new district and new city levels will provide further in-depth interpretations of the local life and health technology industry development plans, addressing questions and clarifying uncertainties for enterprises seeking to establish operations in various specialized sectors.

If your company is interested in establishing a local presence, please scan the QR code below and provide the relevant information. We look forward to connecting with you.